Background Patients with atrial fibrillation (AF) are frequently nonadherent to oral
anticoagulants (OACs) prescribed for prevention of stroke and systemic embolism (SSE) …

Background Adherence to direct oral anticoagulants (DOACs) remains a concern among
non‐valvular atrial fibrillation (AF) patients. We aimed to assess patterns of adherence with …

Few studies assessed the association between major adverse cardiovascular events and
adherence to warfarin and direct oral anticoagulants (DOACs) in patients with atrial …

Introduction: Medicines don't work in those who don't take them. Although novel oral
anticoagulants (NOACs) are more convenient than warfarin due to fewer drug-drug …

Introduction Atrial fibrillation (AF) is one of the leading causes of cerebrovascular mortality
and morbidity. Oral anticoagulants (OACs) have been shown to reduce the incidence of …

Background In comparison to warfarin, non–vitamin K antagonist oral anticoagulants (NOAC
s) have the advantages of ease of dosing, fewer drug interactions, and lack of need for …

Objectives To explore the implications of adherence to oral anticoagulants (OACs) on all-
cause mortality and cardiovascular outcomes in patients with atrial fibrillation (AF). Methods …

BACKGROUND Medication nonadherence is common in AF patients prescribed oral
anticoagulants (OACs) for stroke prevention. Nonadherence to direct OACs (DOACs) is a …

Background: Stroke reduction with direct oral anticoagulants (DOACs) in atrial fibrillation
(AF) is dependent on adherence and persistence in the real-world setting. Individual study …

Purpose Poor adherence to non-vitamin K antagonist oral anticoagulants (NOACs) may
raise thromboembolic risks in patients with atrial fibrillation (AF). However, the minimal …